---
title: "DNTH.US (DNTH.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/DNTH.US/news.md"
symbol: "DNTH.US"
name: "DNTH.US"
parent: "https://longbridge.com/zh-HK/quote/DNTH.US.md"
datetime: "2026-03-17T23:25:07.757Z"
locales:
  - [en](https://longbridge.com/en/quote/DNTH.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DNTH.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DNTH.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/DNTH.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/DNTH.US/news.md)


# DNTH.US (DNTH.US) — 相關新聞

### [Dianthus Therapeutics Hits Early “Go” in CAPTIVATE Phase 3 CIDP Trial, Drops 600 mg Arm](https://longbridge.com/zh-HK/news/279156809.md)
*2026-03-15T12:49:53.000Z*
> Dianthus Therapeutics (NASDAQ:DNTH) has decided to continue its CAPTIVATE Phase 3 trial for claseprubart in chronic infl

### [Dianthus Therapeutics Executives Sell Off Significant Shares](https://longbridge.com/zh-HK/news/279102881.md)
*2026-03-14T00:40:00.000Z*
> Dianthus Therapeutics executives sold significant shares on March 12, 2026, under a Rule 10b5-1 trading plan. Chief Acco

### [BUZZ-Dianthus Therapeutics slips premarket after increased $625 mln share sale](https://longbridge.com/zh-HK/news/278719260.md)
*2026-03-11T12:16:16.000Z*
### [Dianthus Prices $625 Mln Offering To Advance Claseprubart And Broader Autoimmune Pipeline; Stock Up](https://longbridge.com/zh-HK/news/278675309.md)
*2026-03-11T07:30:38.000Z*
> Dianthus Therapeutics, Inc. has announced a $625 million public offering to advance its autoimmune and neuromuscular dis

### [Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering | DNTH Stock News](https://longbridge.com/zh-HK/news/278647604.md)
*2026-03-10T18:55:39.000Z*
> Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering | DNTH Stock News

### [](https://longbridge.com/zh-HK/news/278605532.md)
*2026-03-10T18:18:07.000Z*
> Dianthus Therapeutics shares are trading higher after multiple analyst firms raised their respective price targets on th

### [AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks](https://longbridge.com/zh-HK/news/278498091.md)
*2026-03-10T06:00:43.000Z*
> Dianthus Therapeutics, Inc. (DNTH) has revealed new risks associated with the integration of artificial intelligence, wh

### [Dianthus Therapeutics (NASDAQ:DNTH) Sets New 1-Year High Following Analyst Upgrade](https://longbridge.com/zh-HK/news/278496737.md)
*2026-03-10T05:49:02.000Z*
> Dianthus Therapeutics (NASDAQ:DNTH) shares reached a new 52-week high of $84.86 after HC Wainwright upgraded its price t

### [Top 10 US Stock Gainers (3.9)](https://longbridge.com/zh-HK/news/278452453.md)
*2026-03-09T22:00:51.000Z*
> Relmada Therapeutics(RLMD) rose 61.12%, with a trading turnover 277.6 Million USD, and a year-to-date rose 48.4%. Xenon